{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-095633","form_type":"8-K","ticker":"IRON","cik":"0001816736","company_name":"Disc Medicine, Inc.","filed_at":"2022-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.454906+00:00","generated_at":"2026-06-26T09:31:55.099451+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Gemini Therapeutics CMO Samuel Barone to depart April 15, 2022; advisory role continues","bullets":["Dr. Samuel Barone will leave as Chief Medical Officer effective April 15, 2022.","He receives 9 months base salary severance, pro-rata 2022 target bonus, and 9 months COBRA.","Barone will stay on as advisor, continuing to vest in existing equity during the advisory period.","Retention Agreement terms from Oct 4, 2021 govern severance; general release required."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-095633","json":"https://secwatch.observer/filing/0001193125-22-095633.json","markdown":"https://secwatch.observer/filing/0001193125-22-095633.md","text":"https://secwatch.observer/filing/0001193125-22-095633.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816736/000119312522095633/0001193125-22-095633-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816736/000119312522095633/d345871d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:31:55.099451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"285955961e","claim":"Samuel Barone departed as Chief Medical Officer at Disc Medicine, Inc..","evidence_excerpt":"Effective as of April 15, 2022 (the “Separation Date”), Samuel Barone, M.D. will depart as the Chief Medical Officer of Gemini Therapeutics, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312522095633/0001193125-22-095633-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"depart"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}